Assessment of plasma β-Amyloid 1-42/1-40 ratio may help identify patients with Alzheimer’s Disease
Click here to learn more
Early Results from the BRCA Founder OutReach (BFOR) Study
Read more here
Which of your patients should be offered genetic testing for cancer risk in 2019?
Find out why our new PrEP Panel offering is a game changer!
Watch our video podcast here
Laboratory Blood-Based Testing for Lyme Disease at a National Reference Laboratory (2010-2016)
Read more here.
Non-invasive prenatal cell-free DNA screening
A recent study indicates high specificity and sensitiivity not only for women at high-risk, but also for women at average risk.
Screening for Sexually Transmitted Infections
Learn more by watching our short educational vignette here
Dr Gersh Identifies the chronic conditions that disproportionately impact women, explains the link between certain chronic conditions and women’s cardiometabolic risk and describes what steps... Read more ▸
You will learn how advanced biomarker testing can help maximize team and player performance in this exclusive webinar with Pratik Patel, MS, RD, CSSD, CSCS,... Read more ▸
Dr Jones and Dr Starolis will describe the various organisms and diseases that cause major tick-borne illnesses, the available testing options and which to choose... Read more ▸
Expert InsightsView All Expert Insights ▸
PublicationsView All Publications ▸
Nassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.Krainev AA, Mathavan VK, Klink DF, Saxe JM, Ong GKB, Murphy JK.
J Surg Case Rep. 2019 Jun 28;2019(6):rjz196.
Nassar A, Cohen C, Zhou W, Lynch KA, Barker EA, Vanderbilt BL, Thompson J, Heyman ER, Olson A, Lange H, Siddiqui MT.Amatuni GS, Sciortino S, Currier RJ, Church JA, Puck JM.
J Allergy Clin Immunol 2019 Jun 17. pii: S0091-6749(19)30765-1. doi: 10.1016/j.jaci.2019.05.038. [Epub ahead of print]